212 related articles for article (PubMed ID: 12149142)
1. DNA hypermethylation status of multiple genes in prostate adenocarcinomas.
Konishi N; Nakamura M; Kishi M; Nishimine M; Ishida E; Shimada K
Jpn J Cancer Res; 2002 Jul; 93(7):767-73. PubMed ID: 12149142
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous methylation and deletion patterns of the INK4a/ARF locus within prostate carcinomas.
Konishi N; Nakamura M; Kishi M; Nishimine M; Ishida E; Shimada K
Am J Pathol; 2002 Apr; 160(4):1207-14. PubMed ID: 11943705
[TBL] [Abstract][Full Text] [Related]
3. Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas.
Nakamura M; Sakaki T; Hashimoto H; Nakase H; Ishida E; Shimada K; Konishi N
Cancer Res; 2001 Sep; 61(17):6335-9. PubMed ID: 11522621
[TBL] [Abstract][Full Text] [Related]
4. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
[TBL] [Abstract][Full Text] [Related]
5. CpG island methylation of tumor-related genes in three primary central nervous system lymphomas in immunocompetent patients.
Gonzalez-Gomez P; Bello MJ; Arjona D; Alonso ME; Lomas J; Amiñoso C; de Campos JM; Sarasa JL; Gutierrez M; Rey JA
Cancer Genet Cytogenet; 2003 Apr; 142(1):21-4. PubMed ID: 12660028
[TBL] [Abstract][Full Text] [Related]
6. Impaired expression and promotor hypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues.
Choy KW; Pang CP; To KF; Yu CB; Ng JS; Lam DS
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1344-9. PubMed ID: 11980845
[TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic alteration profiles for multiple genes in salivary gland carcinomas.
Kishi M; Nakamura M; Nishimine M; Ikuta M; Kirita T; Konishi N
Oral Oncol; 2005 Feb; 41(2):161-9. PubMed ID: 15695118
[TBL] [Abstract][Full Text] [Related]
8. Concurrent methylation of multiple genes in childhood ALL: Correlation with phenotype and molecular subgroup.
Gutierrez MI; Siraj AK; Bhargava M; Ozbek U; Banavali S; Chaudhary MA; El Solh H; Bhatia K
Leukemia; 2003 Sep; 17(9):1845-50. PubMed ID: 12970785
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.
Caca K; Feisthammel J; Klee K; Tannapfel A; Witzigmann H; Wittekind C; Mössner J; Berr F
Int J Cancer; 2002 Feb; 97(4):481-8. PubMed ID: 11802210
[TBL] [Abstract][Full Text] [Related]
10. Aberrant gene promoter methylation of E-cadherin, p16
Burassakarn A; Pientong C; Sunthamala N; Chuerduangphui J; Vatanasapt P; Patarapadungkit N; Kongyingyoes B; Ekalaksananan T
Med Oncol; 2017 Jul; 34(7):128. PubMed ID: 28573642
[TBL] [Abstract][Full Text] [Related]
11. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T
Clin Cancer Res; 2003 Oct; 9(13):4884-90. PubMed ID: 14581362
[TBL] [Abstract][Full Text] [Related]
12. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502
[TBL] [Abstract][Full Text] [Related]
13. Aberrant hypermethylation of p14ARF and O6-methylguanine-DNA methyltransferase genes in astrocytoma progression.
Watanabe T; Katayama Y; Yoshino A; Yachi K; Ohta T; Ogino A; Komine C; Fukushima T
Brain Pathol; 2007 Jan; 17(1):5-10. PubMed ID: 17493032
[TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation profile of cell cycle regulator genes in pituitary adenomas.
Yoshino A; Katayama Y; Ogino A; Watanabe T; Yachi K; Ohta T; Komine C; Yokoyama T; Fukushima T
J Neurooncol; 2007 Jun; 83(2):153-62. PubMed ID: 17216555
[TBL] [Abstract][Full Text] [Related]
15. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation.
Smeds J; Berggren P; Ma X; Xu Z; Hemminki K; Kumar R
Carcinogenesis; 2002 Apr; 23(4):645-55. PubMed ID: 11960918
[TBL] [Abstract][Full Text] [Related]
16. Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling.
Lindsey JC; Lusher ME; Anderton JA; Bailey S; Gilbertson RJ; Pearson AD; Ellison DW; Clifford SC
Carcinogenesis; 2004 May; 25(5):661-8. PubMed ID: 14688019
[TBL] [Abstract][Full Text] [Related]
17. DNA hypermethylation status of multiple genes in papillary thyroid carcinomas.
Ishida E; Nakamura M; Shimada K; Higuchi T; Takatsu K; Yane K; Konishi N
Pathobiology; 2007; 74(6):344-52. PubMed ID: 18087199
[TBL] [Abstract][Full Text] [Related]
18. Relationship between alterations of p16(INK4a) and p14(ARF) genes of CDKN2A locus and gastric carcinogenesis.
Tang S; Luo H; Yu J; Yang D; Shu J
Chin Med J (Engl); 2003 Jul; 116(7):1083-7. PubMed ID: 12890389
[TBL] [Abstract][Full Text] [Related]
19. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
Xu XL; Yu J; Zhang HY; Sun MH; Gu J; Du X; Shi DR; Wang P; Yang ZH; Zhu JD
World J Gastroenterol; 2004 Dec; 10(23):3441-54. PubMed ID: 15526363
[TBL] [Abstract][Full Text] [Related]
20. p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer.
Kawamoto K; Enokida H; Gotanda T; Kubo H; Nishiyama K; Kawahara M; Nakagawa M
Biochem Biophys Res Commun; 2006 Jan; 339(3):790-6. PubMed ID: 16316628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]